Compare Tempo Scan Pacific Tbk. (TSPC) vs Wintermar Offshore Marine Tbk. (WINS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Tempo Scan Pacific Tbk. vs Wintermar Offshore Marine Tbk. — how do they compare? Tempo Scan Pacific Tbk. trades at Rp2,730 (market cap 12.36T, 1.41M 24h volume), while Wintermar Offshore Marine Tbk. trades at Rp620 (market cap 2.49T, 7.76M 24h volume). The key difference: Tempo Scan Pacific Tbk. is far larger — about 5× Wintermar Offshore Marine Tbk.'s market cap, and Wintermar Offshore Marine Tbk. is more actively traded (7.76M versus 1.41M). Which is the better fit depends on your goals.
| TSPC | WINS | |
|---|---|---|
Market Cap | 12.36T | 2.49T |
Volume | 1.41M | 7.76M |
Lot | 14.08K | 77.6K |
Turnover | 3.83B | 4.7B |
Average Price | 2,722.04 | 606.21 |
Value | 3.83B | 4.7B |
Indicative Equilibrium Price | 2,730 | 620 |
Indicative Equilibrium Volume | 2.51K | 3.81K |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Tempo Scan Pacific Tbk.
PT. Tempo Scan Pacific Tbk (the Company) was established in the Republic of Indonesia dated 20 May 1970, under its original name PT Scanchemie within the framework of the Domestic Capital Investment Law No. 6 year 1968, as amended by Law No. 12 year 1970, based on Notarial Deed No. 37 of Ridwan Suselo, S.H. The company is famous for such pharmaceutical products as Bodrex, Hemaviton and Neo-Rheumacyl.
Read more on TSPC →About Wintermar Offshore Marine Tbk.
PT Wintermar Offshore Marine Tbk (the Company) was established under its original name of PT Swakarya Mulia Shipping base on notarial deed No.98 of Mrs Trisnawati Mulia, S.H, dated on 18 Dec, 1995. The Companys articles of association has been amended several times, most recently by notarial deed No. 15 of Fathiah Helmi, S.H., dated Sep 16, 2010, concerning among others, change in company's name, par value and public offering.
Read more on WINS →
